Cell and gene therapy: Dr. Jeff Hersh examines 25 years of technological advances In general, earlier stage cancers have ...

Over the past few decades, there have been major advancements in cancer treatment, with more focused and less harmful choices ...

In recent years, Black patients with triple-negative breast cancer (TNBC) received immunotherapy at significantly lower rates ...

The American Association for Cancer Research's latest Cancer Progress Report highlights the risk posed by several viral and ...

Researchers investigated differences in T-cell responses between male and female patients with lung cancer that may help direct future treatments. T-cell responses are part of the adaptive immune ...

Adjuvant cancer treatments such as chemotherapy and radiation are given after a primary cancer treatment to help prevent ...

In head-to-head clinical trial, Chinese firm Akeso’s ivonescimab beat top-selling drug pembrolizumab sold as Keytruda by ...

Glycans play an important role in modulating the interactions between natural killer cells and antibodies to fight pathogens and harmful cells.

Due to the remarkable success of the Research Topic 'New Insights in Veterinary Cancer Immunology' and the rapidly evolving subject area, we are pleased to launch Volume II for this topic. The tumour ...

Neoadjuvant therapy is an essential part of high-risk stage III resectable melanoma management, with combination ...

Advances in treatment and new drugs are pushing cancer care even farther away from hospital campuses into outpatient settings ...

T cells are our first line of defense against cancer, but the battle tends to exhaust them. Now, scientists have found a way ...